Update Breast Cancer 2022 Part 2 – Advanced Stage Breast Cancer

For patients with advanced breast cancer, several novel therapies have emerged in recent years, including CDK4/6 inhibitors, immune checkpoint inhibitors, PARP inhibitors, alpelisib, tucatinib and trastuzumab-deruxtecan, and sacituzumab-govitecan, which have transformed and expanded the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Volkmar, Welslau, Manfred, Lüftner, Diana, Schütz, Florian, Stickeler, Elmar, Fasching, Peter A., Janni, Wolfgang, Thomssen, Christoph, Witzel, Isabell, Fehm, Tanja N., Belleville, Erik, Bader, Simon, Seitz, Katharina, Untch, Michael, Thill, Marc, Tesch, Hans, Ditsch, Nina, Lux, Michael P., Aktas, Bahriye, Banys-Paluchowski, Maggie, Schneeweiss, Andreas, Harbeck, Nadia, Würstlein, Rachel, Hartkopf, Andreas D., Kolberg, Hans-Christian, Wöckel, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315399/
https://www.ncbi.nlm.nih.gov/pubmed/35903715
http://dx.doi.org/10.1055/a-1811-6148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315399/
https://www.ncbi.nlm.nih.gov/pubmed/35903715
http://dx.doi.org/10.1055/a-1811-6148

Ejemplares similares